<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100820</article-id><article-id pub-id-type="doi">10.7554/eLife.100820</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.100820.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>T3SS translocon induces pyroptosis by direct interaction with NLRC4/NAIP inflammasome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Yan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0001-3874-7770</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Hanshuo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jinqian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Hang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1378-5922</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Sun</surname><given-names>Li</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7183-7148</contrib-id><email>lsun@qdio.ac.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/018yw5541</institution-id><institution>CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Institute of Oceanology; CAS Center for Ocean Mega-Science, Chinese Academy of Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03cve4549</institution-id><institution>Tsinghua University-Peking University Joint Center for Life Sciences, School of Basic Medical Sciences, Tsinghua University</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/026sv7t11</institution-id><institution>Laboratory for Marine Biology and Biotechnology, Qingdao Marine Science and Technology Center</institution></institution-wrap><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qbk4x57</institution-id><institution>College of Marine Sciences, University of Chinese Academy of Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004eeze55</institution-id><institution>NHC Key Laboratory of Tropical Disease Control, School of Tropical Medicine, Hainan Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Haikou</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sohn</surname><given-names>Jungsan</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Johns Hopkins University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/028qa3n13</institution-id><institution>Indian Institute of Science Education and Research (IISER)</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>14</day><month>02</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP100820</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-07-11"><day>11</day><month>07</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-07-16"><day>16</day><month>07</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.07.11.603062"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-29"><day>29</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100820.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-01-31"><day>31</day><month>01</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.100820.2"/></event></pub-history><permissions><copyright-statement>© 2024, Zhao et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Zhao et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-100820-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-100820-figures-v1.pdf"/><abstract><p>Type III secretion system (T3SS) is a virulence apparatus existing in many bacterial pathogens. Structurally, T3SS consists of the base, needle, tip, and translocon. The NLRC4 inflammasome is the major receptor for T3SS needle and basal rod proteins. Whether other T3SS components are recognized by NLRC4 is unclear. In this study, using <italic>Edwardsiella tarda</italic> as a model intracellular pathogen, we examined T3SS−inflammasome interaction and its effect on cell death. <italic>E. tarda</italic> induced pyroptosis in a manner that required the bacterial translocon and the host inflammasome proteins of NLRC4, NLRP3, ASC, and caspase 1/4. The translocon protein EseB triggered NLRC4/NAIP-mediated pyroptosis by binding NAIP via its C-terminal region, particularly the terminal 6 residues (T6R). EseB homologs exist widely in T3SS-positive bacteria and share high identities in T6R. Like <italic>E. tarda</italic> EseB, all of the representatives of the EseB homologs exhibited T6R-dependent NLRC4 activation ability. Together these results revealed the function and molecular mechanism of EseB to induce host cell pyroptosis and suggested a highly conserved inflammasome-activation mechanism of T3SS translocon in bacterial pathogens.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>T3SS</kwd><kwd>translocon</kwd><kwd>NLRC4</kwd><kwd>pathogen-host interaction</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Science &amp; Technology Innovation Project of Laoshan Laboratory</institution></institution-wrap></funding-source><award-id>LSKJ202203000</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Li</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31330081</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Li</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012166</institution-id><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2018YFD0900500</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Li</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>T3SS translocon induces NLRC4-mediated cell death via a conserved C-terminal region shared by many T3SS-positive bacterial pathogens.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The host innate immune system responds to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) via multiple pattern recognition receptors (PRRs). Inflammasomes are a group of cytoplasmic PRRs that detect intracellular pathogens or disruptions in cellular homeostasis (<xref ref-type="bibr" rid="bib5">Christgen et al., 2020</xref>). NLRP1, NLRP3, NLRC4, AIM2, and Pyrin are well-established PRRs that always combine with the adaptor protein ASC to form canonical inflammasomes, which activate the effector protein caspase-1 (Casp1), leading to the processing and release of interleukin (IL) –1β and IL-18 (<xref ref-type="bibr" rid="bib15">Kanneganti, 2020</xref>). Casp1 can also cleave and activate gasdermin (GSDM) D, which subsequently forms channels in the plasma membrane, eventually leading to a type of lytic programmed cell death called pyroptosis (<xref ref-type="bibr" rid="bib12">He et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Shi et al., 2015</xref>). In the non-canonical pathway, Casp4/5 (in humans) and Casp11 (in mice) are activated by bacterial lipopolysaccharide (LPS) and trigger GSDMD-mediated pyroptosis (<xref ref-type="bibr" rid="bib33">Shi et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Kayagaki et al., 2015</xref>). Of these inflammasomes, NLRC4 responds to Gram-negative bacterial ligands, primarily flagellin, and components of the T3SS apparatus, in a manner that requires an upstream immune sensor protein called NLR-family apoptosis inhibitory protein (NAIP), which interacts directly with the PAMPs (<xref ref-type="bibr" rid="bib26">Miao et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Zhao et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Reyes Ruiz et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Kofoed and Vance, 2011</xref>). Mice possess several NAIPs, each of which detects specific bacterial ligands, while humans possess only one functional NAIP (hNAIP) that is capable of broadly recognizing multiple bacterial ligands (<xref ref-type="bibr" rid="bib45">Zhao et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Reyes Ruiz et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Kofoed and Vance, 2011</xref>; <xref ref-type="bibr" rid="bib42">Yang et al., 2013</xref>).</p><p><italic>Edwardsiella tarda</italic> belongs to the Enterobacteriaceae family. It is an intracellular pathogen and can survive and replicate in host immune cells, such as macrophages (<xref ref-type="bibr" rid="bib35">Sui et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Li et al., 2019</xref>). <italic>E. tarda</italic> has a broad range of hosts, including fish and humans (<xref ref-type="bibr" rid="bib19">Leung et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Leung et al., 2019</xref>). In humans, <italic>E. tarda</italic> has been reported to cause gastrointestinal diseases and systemic infections that can be lethal (<xref ref-type="bibr" rid="bib13">Hirai et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Leung et al., 2022</xref>). <italic>E. tarda</italic> possesses T3SS and uses it to modulate the host immune systems (<xref ref-type="bibr" rid="bib19">Leung et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">Leung et al., 2022</xref>). T3SS functions as an injectisome that delivers bacterial effector proteins into host cells. The T3SS apparatus consists of three distinct parts— the extracellular segment, the basal body, and the cytoplasmic components (<xref ref-type="bibr" rid="bib28">Portaliou et al., 2016</xref>). The extracellular part comprises the needle, tip, and translocon, which spans the host cell membrane (<xref ref-type="bibr" rid="bib8">Dey et al., 2019</xref>). In <italic>E. tarda</italic>, the translocon complex is formed by EseB, EseC, and EseD (<xref ref-type="bibr" rid="bib36">Tan et al., 2005</xref>). Genetically, the <italic>eseB</italic>, <italic>escA</italic>, <italic>eseC</italic>, and <italic>eseD</italic> genes clustered in tandem in the same operon. In function, EscA acts as a specific chaperone for EseC (<xref ref-type="bibr" rid="bib38">Wang et al., 2009</xref>). The translocon is known to be essential for the pathogenesis of <italic>E. tarda</italic> (<xref ref-type="bibr" rid="bib36">Tan et al., 2005</xref>; <xref ref-type="bibr" rid="bib38">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib27">Okuda et al., 2009</xref>), but the mechanism, in particular, that is associated with inflammasome activation and pyroptosis, remains to be explored.</p><p>In this study, using <italic>E. tarda</italic> as an intracellular pathogen model and human macrophages as the host cells, we investigated the function and the working mechanism of the T3SS translocon in pathogen-host interaction. We found that <italic>E. tarda</italic> induced GSDMD-dependent pyroptosis involving both canonical and non-canonical inflammasomes, and that the translocon proteins were indispensable for <italic>E. tarda</italic> cytotoxicity. We examined the role and mechanism of EseB in host interaction and uncovered the key structure of EseB that was essential for binding and activating the NLRC4/NAIP inflammasome. Furthermore, we identified EseB homologs in a broad range of bacteria and demonstrated that NLRC4/NAIP interaction and activation was probably a conserved function of the EseB homologs in T3SS-positive bacterial pathogens. These results added new insight into the working mechanism of EseB and highlighted the important role of the translocon in bacteria-host interaction.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>E. tarda</italic> triggers GSDMD-dependent pyroptosis in human macrophages</title><p>To examine whether <italic>E. tarda</italic> infection triggered cell death in human macrophages, differentiated THP-1 cells (dTHP-1 cells) were infected with <italic>E. tarda</italic>. The cells were found to undergo rapid cell death as indicated by LDH release (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). However, cell death was almost completely blocked when the cells were pre-treated with cytochalasin B (CytoB) or cytochalasin D (CytoD), which inhibited bacterial entry into the cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Hence, it was intracellular <italic>E. tarda</italic>, rather than extracellular bacteria, that induced cell death in human macrophages. Further examination showed that <italic>E. tarda</italic>-infected dTHP-1 cells exhibited a swelling morphology, accompaniedby IL-1β release, Casp1 activation, and GSDMD cleavage (<xref ref-type="fig" rid="fig1">Figure 1A–E</xref>). These observations indicated that <italic>E. tarda</italic> triggered pyroptosis in dTHP-1 cells. To examine whether and which inflammasomes were involved in this process, cells defective in various inflammasome pathways were employed. The results showed that following <italic>E. tarda</italic> infection for 2 hr or 4 hr, cell death and IL-1β release were significantly decreased in NLRC4 knockout (NLRC4-KO) cells, Casp4 knockout (Casp4-KO) cells, and NLRP3 knockdown (NLRP3-KD) cells (at 4 hr post-infection), but not in Aim2 knockout (Aim2-KO) cells (<xref ref-type="fig" rid="fig1">Figure 1F–I</xref>). Cells with Casp1 knockdown (Casp1-KD), GSDMD knockout (GSDMD-KO), and ASC knockout (ASC -KO) all exhibited significantly decreased cell death and IL-1β release (<xref ref-type="fig" rid="fig1">Figure 1F–I</xref>). Taken together, these results indicated that intracellular <italic>E. tarda</italic> induced GSDMD-dependent pyroptosis in human macrophages in a manner that required NLRC4, NLRP3, ASC, Casp1, and Casp4.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The ability of <italic>Edwardsiella tarda</italic> to induce pyroptosis in human macrophages.</title><p>(<bold>A</bold>) The schematic of experimental design. (<bold>B–E</bold>) Differentiated THP-1 (dTHP-1) cells were infected with <italic>E. tarda</italic> for the indicated hours and then subjected to microscopy (<bold>B</bold>), measurement of cell death (<bold>C</bold>), IL-1β release (<bold>D</bold>), and Western blot (<bold>E</bold>) using antibodies against Casp1, GSDMD, and β-actin (loading control). In (<bold>B</bold>), red arrowheads indicate pyroptotic cells; scale bar, 10 μm. (<bold>F–I</bold>) dTHP-cells in the form of wild-type (WT), knockout (KO) variants (Aim2-KO, NLRC4-KO, ASC-KO, Casp4-KO, and GSDMD-KO), and knockdown (KD) variants (NLRP3-KD and Casp1-KD) were infected with or without <italic>E. tarda</italic> for 2 or 4 hr, and then assessed for cell death (<bold>F, H</bold>) and IL-1β release (<bold>G, I</bold>). For panels C, D, and F-I, data were the means of triplicate assays and shown as means ± SD. ns, not significant, ***p&lt;0.001, ****p&lt;0.0001, one-way ANOVA with Dunnett’s multiple-comparison test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig1">Figure 1E</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig1">Figure 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The effect of cytochalasin B (CytoB) and cytochalasin D (CytoD) on the ability of <italic>Edwardsiella tarda</italic> to induce cell death.</title><p>(<bold>A</bold>) Differentiated THP-1 (dTHP-1) cells pretreated with or without DMSO, CytoB, or CytoD were infected with or without <italic>E. tarda</italic> for 2 hr and then determined for cell death. (<bold>B</bold>) dTHP-1 cells pretreated with or without DMSO, CytoB, or CytoD were infected with or without <italic>E. tarda</italic> for 1 hr. The extracellular bacteria were killed by gentamycin. The intracellular bacteria were quantified by plate count. Data are the means of triplicate assays and are shown as means ± SD. ****p&lt;0.0001, one-way ANOVA with Dunnett’s multiple-comparison test.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>The T3SS translocon is essential to <italic>E. tarda-</italic>induced pyroptosis</title><p>Similar to most intracellular Gram-negative bacterial pathogens, <italic>E. tarda</italic> possesses a T3SS system and uses it as a weapon against host immunity. In this system, EseB, EseC, and EseD form a translocon, with EscA acting as an EseC chaperone. To investigate the potential role of the translocon in pyroptosis, a series of <italic>E. tarda</italic> mutants were constructed, which bear the knockout of <italic>eseB</italic>, <italic>escA</italic>, <italic>eseC</italic>, or <italic>eseD</italic> (Δ<italic>eseB</italic>, Δ<italic>escA</italic>, Δ<italic>eseC</italic>, or Δ<italic>eseD</italic>, respectively), or the knockout of all of the four genes (Δ<italic>eseB-D</italic>) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Compared with the wild-type, these mutants showed no deficiency in host cell adhesion or entry (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). However, Δ<italic>eseB-D</italic>, Δ<italic>eseB</italic>, Δ<italic>eseC</italic>, and Δ<italic>eseD</italic> were unable to induce host cell death, IL-1β release, Casp1 activation, or GSDMD cleavage following infection (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). Casp4 activation was also absent in Δ<italic>eseB-D</italic>-infected cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Δ<italic>escA</italic> was still able to induce pyroptosis, but the levels of cell death and IL-1β release were significantly lower than that induced by the wild-type (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). To examine whether flagellin was required for <italic>E. tarda</italic>-induced pyroptosis, the flagellin mutant, Δ<italic>fliC</italic>, was created. Compared with the wild-type (WT), Δ<italic>fliC</italic> exhibited no significant change in host cell adhesion/entry, cell death induction, Casp1 activation, or GSDMD cleavage (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). These results indicated that the T3SS translocon proteins, rather than flagellin, were indispensable for <italic>E. tarda</italic>-induced pyroptosis.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The importance of the translocon for <italic>Edwardsiella tarda-</italic>induced pyroptosis.</title><p>(<bold>A</bold>) A diagram showing the in-frame deletion (red curved line) of <italic>eseB-D</italic>, <italic>escA</italic>, <italic>eseB</italic>, <italic>eseC,</italic> and <italic>eseD</italic>. (<bold>B, C</bold>) Differentiated THP-1 (dTHP-1) cells were infected with wild-type (WT) or mutant <italic>E. tarda</italic> for 1 hr. The intracellular bacteria (<bold>B</bold>) and the total bacteria associated with the cells (i.e. both the cell-attached and the intracellular bacteria) (<bold>C</bold>) were determined by plate count. (<bold>D–F</bold>) dTHP-1 cells were treated with or without <italic>E. tarda</italic> variants for 2 or 4 hr, and then subjected to cell death analysis (<bold>D</bold>), IL-1β release measurement (<bold>E</bold>), and immunoblot (<bold>F</bold>) using antibodies against Casp1, GSDMD, and β-actin (loading control). For panels B-E, data are the means of triplicate assays and are shown as means ± SD. ns, not significant, ****p&lt;0.0001, one-way ANOVA with Dunnett’s multiple-comparison test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig2">Figure 2F</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig2">Figure 2F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig2-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The effect of Δ<italic>eseB-D</italic> on Casp4 activation.</title><p>(<bold>A</bold>) Differentiated THP-1 (dTHP-1) cells were treated with wild-type (WT) <italic>Edwardsiella tarda</italic> or the Δ<italic>eseB-D</italic> mutant for 2 hr or 4 hr. The cells were subjected to cell death analysis (<bold>A</bold>) and immunoblot with antibodies against Casp4 and β-actin (<bold>B</bold>). Data in panel A are the means of triplicate assays and are shown as means ± SD.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig2-figsupp1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata2"><label>Figure 2—figure supplement 1—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig2-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s1sdata3"><label>Figure 2—figure supplement 1—source data 3.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig2-figsupp1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>The involvement of flagellin in <italic>Edwardsiella tarda</italic>-induced pyroptosis of human macrophages.</title><p>(<bold>A, B</bold>) Differentiated THP-1 (dTHP-1) cells were infected with <italic>E. tarda</italic> wild-type (WT) or Δ<italic>fliC</italic> for 1 hr. The intracellular bacteria (<bold>A</bold>) and the total bacteria associated with the cells (<bold>B</bold>) were determined by plate count. (<bold>C, D</bold>) dTHP-1 cells were treated with or without <italic>E. tarda</italic> WT or Δ<italic>fliC</italic> for 2 or 4 hr, and then subjected to cell death analysis (<bold>C</bold>) and immunoblotting with antibodies against Casp1, GSDMD, and β-actin (<bold>D</bold>). Data in panels A-C are the means of triplicate assays and are shown as means ± SD. ns, not significant; p&gt;0.05, Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig2-figsupp2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata2"><label>Figure 2—figure supplement 2—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig2-figsupp2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata3"><label>Figure 2—figure supplement 2—source data 3.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig2-figsupp2-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig2-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Cytosolic EseB triggers pyroptosis in a NLRC4/NAIP-dependent manner</title><p>To examine the mechanism underlying the above observed essentialness of the translocon in <italic>E. tarda</italic>-induced cell death, the recombinant proteins of EscA, EseB, EseC, and EseD were prepared (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The effects of these proteins, both extracellular and intracellular, on THP-1 cells were determined. When present in the extracellular milieu, none of these proteins caused an apparent change to the cell morphology (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). However, when EseB was present in the cytoplasm of THP-1 cells, pyroptotic cell death, including activation of Casp1 and GSDMD, was observed (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). To examine which inflammasome pathway was involved in this process, the effect of EseB was determined using Aim2/NLRC4/ASC/Casp4/GSDMD knockout cells and NLRP3/Casp1 knockdown cells. The results showed that defective in NLRC4, GSDMD, and Casp1, but not in AIM2, Casp4, or NLRP3, rendered the cells markedly immune to the death-inducing effect of EseB (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>). ASC knockout also significantly, though to a relatively modest extent, reduced EseB-induced cell death. Since NAIP is known to be involved in NLRC4 inflammasome activation, the effect of NAIP knockdown on EseB cytotoxicity was examined. The result showed that the NAIP-knockdown cells exhibited significantly decreased death following EseB treatment (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>). Collectively, these results indicated that cytosolic EseB, rather than extracellular EseB, induced pyroptosis via the NLRC4/NAIP inflammasome.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The pyroptotic effect of the translocon proteins and their dependence on the inflammasomes.</title><p>(<bold>A–C</bold>) To determine the extracellular and intracellular effects of EscA, EseB, EseC, and EseD, each of the proteins was added into the culture medium of THP-1 cells (extracellular) or electroporated into THP-1 cells (intracellular). The control cells were mock-treated with PBS. The cells were subjected to microscopy (<bold>A</bold>), cell death analysis (<bold>B</bold>), and immunoblot using antibodies against Casp1, GSDMD, and β-actin (loading control) (<bold>C</bold>). In (<bold>A</bold>), red arrowheads indicate pyroptotic cells; scale bar, 10 μm. (<bold>D</bold>) The wild-type (WT) and knockout (KO) THP-1 cells were treated with or without extracellular and intracellular EseB as above and then examined for cell death. (<bold>E</bold>) The control THP-cells (Null) and the NLRP3/Casp1 knockdown (KD) THP-cells were treated with or without extracellular and intracellular EseB as above and then examined for cells death. (<bold>F</bold>) THP-1 cell treated with or without (Control, Ctrl) NLR-family apoptosis inhibitory protein (NAIP)-targeting shRNA or scramble RNA (negative control RNA) were examined for NAIP expression by qRT-PCR. (<bold>G</bold>) THP-1 cells administered with or without NAIP-targeting or scramble RNA were treated or without extracellular and intracellular EseB as above and then examined for cell death. For panels B, and D-F, data are the means of triplicate assays and are shown as means ± SD. ns, not significant, ***p&lt;0.001, ****p&lt;0.0001, one-way ANOVA with Dunnett’s multiple-comparison test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig3-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig3-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>SDS-PAGE analysis of purified recombinant proteins.</title><p>The purified recombinant translocon proteins of EscA, EseB, EseC, and EseD were subjected to SDS-PAGE and stained with Coomassie brilliant blue R-250.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>PDF file containing the original gels for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig3-figsupp1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Original files for gels are displayed in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig3-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>The C-terminal region of EseB is vital to NAIP interaction and pyroptosis induction</title><p>To explore its mechanism to activate the NLRC4/NAIP pathway, EseB was first subjected to sequence analysis. The C-terminal (CT) region of EseB exhibits notable degrees of conservation, especially in the terminal 6 residues (T6R), with bacterial needle proteins known to activate NLRC4 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Based on this observation, we divided EseB into the N-terminal (NT) (1–112 aa) and the CT (113–198 aa) regions (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). To identify the sequence essential to EseB function, a series of EseB mutants were constructed that bear deletion of the terminal 4 residues (T4R) (EseBΔT4R) or the T6R (EseBΔT6R), or contain only the NT (EseB-NT) or CT (EseB-CT) region (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). When introduced into THP-1 cells, EseB-CT induced cell death and Casp1/GSDMD activation, whereas all other EseB mutants failed to do so (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). The EseB variants were further examined in 293T cells with reconstituted NAIP/NLRC4 inflammasome, in which NAIP/NLRC4 activation could be monitored by analyzing the maturation cleavage of IL-1β (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). The results showed that in cells co-expressing EseB and all NLRC4 inflammasome components, massive IL-1β cleavage occurred (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Similar observations were made with cells co-expressing NAIP/NLRC4 inflammasome and EseB-CT (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Together these results demonstrated that EseB, via its CT region, activated the NAIP/NLRC4 inflammasome. Consistently, immunoprecipitation revealed that EseB, as well as EseB-CT, bound to NAIP, and this binding was not observed with either of the other EseB mutants (<xref ref-type="fig" rid="fig4">Figure 4H, I</xref>). EseB could not bind to NLRC4 directly (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). In addition to EseB, the rod (EsaI), needle (EsaG), and flagellin (FliC1/2) of <italic>E. tarda</italic> were also examined for their ability to activate the NLRC4 inflammasome. For this purpose, these proteins were each co-expressed with NAIP/NLRC4 in 293T cells. Only the needle protein EsaG induced significant IL-1β cleavage (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B, C</xref>). This result indicated that EsaG, but not the rod protein or flagellin, activated NLRC4.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Identification of the functional important region in EseB.</title><p>(<bold>A</bold>) Sequence alignment of EseB and T3SS needle proteins with NLRC4/NAIP-stimulating activity. (<bold>B</bold>) A diagram showing EseB wild-type (WT) and truncates. (<bold>C–E</bold>) THP-1 cells were electroporated with or without (Mock) EseB WT or truncated. The cells were subjected to microscopy (<bold>C</bold>), cell death analysis (<bold>D</bold>), and immunoblot with antibodies against Casp1, GSDMD, and β-actin (loading control) (<bold>E</bold>). In (<bold>C</bold>), red arrowheads indicate pyroptotic cells; scale bar, 10 μm. For panel D, data are the means of triplicate assays and are shown as means ± SD. ns, not significant, ****p&lt;0.0001, one-way ANOVA with Dunnett’s multiple-comparison test. (<bold>F</bold>) A diagram showing the detection of the activating effect of EseB on NAIP/NLRC4 in NLRC4 inflammasome-reconstituted HEK293T cells by determining proIL-1β cleavage. (<bold>G</bold>) HEK293T cells were transfected with or without the indicated combination of vectors expressing Flag-tagged NLRC4, HA-tagged NLR-family apoptosis inhibitory protein (NAIP), Myc-tagged EseB, proCasp1, and proIL-1β for 24 hr. The cells were subjected to immunoblot using antibodies against the tags or the proteins with β-actin as a loading control. (<bold>H</bold>) HEK293T cells were transfected with the indicated combination of vectors expressing Flag-tagged NLRC4, HA-tagged NAIP, and Myc-tagged EseB. The cells were subjected to immunoprecipitation (IP) using antibodies against the tags with β-actin as a loading control. (<bold>I</bold>) HEK293T cells were transfected with the indicated combination of vectors expressing HA-tagged NAIP and Flag-tagged EseB variants. IP was performed as above.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4">Figure 4G</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4">Figure 4G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4">Figure 4H</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-data5-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata6"><label>Figure 4—source data 6.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4">Figure 4H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata7"><label>Figure 4—source data 7.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4">Figure 4I</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-data7-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4sdata8"><label>Figure 4—source data 8.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4">Figure 4I</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-data8-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata9"><label>Figure 4—source data 9.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig4-data9-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>SDS-PAGE analysis of purified recombinant proteins.</title><p>The purified recombinant proteins of EseB truncates were subjected to SDS-PAGE and stained with Coomassie brilliant blue R-250. WT, wild-type.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>PDF file containing the original gel for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-figsupp1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Original file for gel is displayed in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>The ability of <italic>Edwardsiella tarda</italic> EseB, rod (EsaI), needle (EsaG), and flagellin (FliC1/2) to activate NLRC4.</title><p>NLRC4 inflammasome-reconstituted HEK293T cells expressing or not expressing wild type (WT) or mutant EseB (<bold>A</bold>), EsaI/EsaG (<bold>B</bold>), or FliC1/2 (<bold>C</bold>) for 24 h were immunoblotted with antibodies against IL-1β and β-actin (loading control).</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-figsupp2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata2"><label>Figure 4—figure supplement 2—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-figsupp2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata3"><label>Figure 4—figure supplement 2—source data 3.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-figsupp2-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata4"><label>Figure 4—figure supplement 2—source data 4.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-figsupp2-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata5"><label>Figure 4—figure supplement 2—source data 5.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig4-figsupp2-data5-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata6"><label>Figure 4—figure supplement 2—source data 6.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig4-figsupp2-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig4-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>The NLRC4-activation capacity and mechanism of EseB are conserved in pathogenic bacteria</title><p>With the above results, we wondered whether the observed EseB function was unique to <italic>E. tarda</italic> or common in bacterial pathogens with T3SS. To answer this question, we searched and identified EseB homologs in diverse pathogenic bacteria. Among these EseB homologues, 20 were randomly selected, including those from <italic>Salmonella</italic> and <italic>Chromobacterium</italic>, for activity analysis (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The results showed that all of the 20 EseB homologs could activate the NLRC4/NAIP inflammasome in reconstituted 293T cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Phylogenetic analysis of these EseB homologues and <italic>E. tarda</italic> EseB showed that they fell into four groups (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). However, high levels of sequence identities are shared among these EseB at the T6R (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). To examine whether, as observed with <italic>E. tarda</italic> EseB, the T6R was functionally important, five of the 20 EseB homologs were selected for mutation to remove the T6R or T7R. The resulting mutants, like <italic>E. tarda</italic> EseBΔT6R, no longer possessed the ability to activate the NLRC4 inflammasome and cause cell death (<xref ref-type="fig" rid="fig5">Figure 5C, D</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). We further examined the NLRC4-activating potential of bacterial translocators with relatively low sequence identities (&lt;23%) with EseB. For this purpose, 14 key translocator proteins from eight pathogenic bacteria were selected for the examination (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Three of these proteins, i.e., PcrV, SipC, and IpaC, possess terminal 5–7 residues that are similar to the T6R of EseB (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A</xref>). Subsequent study showed that only PcrV (from <italic>Pseudomonas aeruginosa</italic>) was able to activate the NLRC4 inflammasome (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B</xref>). When the terminal five residues (T5R) of PcrV were deleted, the resulting ΔT5R mutant lost the capacity to activate NLRC4 (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3C</xref>). LcrV, which did not activate NLRC4 (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B</xref>), shares a relatively high level (36.3%) of identity with PcrV but differs from PcrV in the T6R (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3D</xref>). Substitution of the T6R of LcrV with the T5R of PcrV enabled the mutant, LcrV-T6RM, to gain the ability to activate NLRC4 inflammasome (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3D</xref>). Similarly, the substitution of the T5R of EspA<sub>EHEC</sub> with the T6R of EseB enabled the mutant, EspA<sub>EHEC</sub>-T5RM, to activate NLRC4 inflammasome (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3E</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The ability of the EseB homologs to activate the NLRC4/NLR-family apoptosis inhibitory protein (NAIP) inflammasome.</title><p>(<bold>A</bold>) NLRC4 inflammasome-reconstituted HEK293T cells were transfected with or without EseB homologs (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The cells were immunoblotted with antibodies against IL-1β and β-actin (loading control). (<bold>B</bold>) Sequence alignment of the C-terminal regions of the EseB homologs. Red stars indicate the EseB selected for mutation analysis. (<bold>C</bold>) NLRC4 inflammasome-reconstituted HEK293T cells expressing or not expressing the indicated EseB homologs or their mutants were immunoblotted as panel A. (<bold>D</bold>) THP-1 cells were electroporated with the indicated EseB homologs or their mutants or PBS (mock) and then determined for cell death. Data are the means of triplicate assays and are shown as means ± SD. ns, not significant, ***p&lt;0.001, ****p&lt;0.0001, Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original files for blots displayed in <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig5">Figure 5C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5sdata4"><label>Figure 5—source data 4.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig5">Figure 5C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata5"><label>Figure 5—source data 5.</label><caption><title>The numerical source data corresponds to <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-100820-fig5-data5-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Phylogenetic analysis of EseB homologs.</title><p>The phylogenetic tree was generated using ClustalW alignment and the Neighbor-Joining method. Red pentagrams indicate the bacteria whose EseB homologs were selected for mutation analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>SDS-PAGE analysis of purified recombinant proteins.</title><p>Purified recombinant EseB homologues (left) and their mutants (right) were subjected to SDS-PAGE and stained with Coomassie brilliant blue R-250. The full names of the proteins are shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>PDF file containing the original gels for <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-figsupp2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s2sdata2"><label>Figure 5—figure supplement 2—source data 2.</label><caption><title>Original files for gels are displayed in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>The effects of translocator proteins on NLRC4/NLR-family apoptosis inhibitory protein (NAIP) inflammasome activation.</title><p>(<bold>A</bold>) Sequence alignment of the C-terminal regions of EseB, PcrV, SipC, and IpaC. (<bold>B</bold>) NLRC4 inflammasome-reconstituted HEK293T cells expressing or not expression (-) the indicated proteins for 24 hr were immunoblotted with antibodies against IL-1β and β-actin (loading control). (<bold>C–E</bold>) NLRC4 inflammasome-reconstituted HEK293T cells expressing or not expression (-) wild-type (WT) and mutant PcrV (<bold>C</bold>), LcrV (<bold>D</bold>), and EspA<sub>EHEC</sub> (<bold>E</bold>) were immunoblotted as above. The C-terminal regions of PcrV, LcrV, and EspA<sub>EHEC</sub> were aligned on top of the panels.</p><p><supplementary-material id="fig5s3sdata1"><label>Figure 5—figure supplement 3—source data 1.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-figsupp3-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata2"><label>Figure 5—figure supplement 3—source data 2.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-figsupp3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata3"><label>Figure 5—figure supplement 3—source data 3.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3C</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-figsupp3-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata4"><label>Figure 5—figure supplement 3—source data 4.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-figsupp3-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata5"><label>Figure 5—figure supplement 3—source data 5.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3D</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-figsupp3-data5-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata6"><label>Figure 5—figure supplement 3—source data 6.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-figsupp3-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata7"><label>Figure 5—figure supplement 3—source data 7.</label><caption><title>PDF file containing the original blots for <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3E</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-100820-fig5-figsupp3-data7-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig5s3sdata8"><label>Figure 5—figure supplement 3—source data 8.</label><caption><title>Original files for blots are displayed in <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-100820-fig5-figsupp3-data8-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100820-fig5-figsupp3-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we examined the mechanism of inflammasome-mediated pyroptosis induced by bacterial T3SS translocon. Well-known inflammasome proteins, such as NLRP3 and NLRC4, and Casp4 are intracellular PRRs that induce pyroptosis during intracellular bacterial infections (<xref ref-type="bibr" rid="bib34">Storek and Monack, 2015</xref>; <xref ref-type="bibr" rid="bib1">Broz and Dixit, 2016</xref>). While NLRP3 activation can occur upon alterations in cellular homeostasis (<xref ref-type="bibr" rid="bib11">Gong et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Hughes and O’Neill, 2018</xref>; <xref ref-type="bibr" rid="bib32">Seoane et al., 2020</xref>), NLRC4 and Casp4 are primarily activated by specific PAMP ligands presented by microbial organisms (<xref ref-type="bibr" rid="bib5">Christgen et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Egan et al., 2023</xref>). Previous studies have demonstrated that <italic>E. tarda</italic> components or secreted particles can cause pyroptosis in murine macrophages and human epithelial cells (<xref ref-type="bibr" rid="bib40">Xie et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib3">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Xu et al., 2018</xref>). In this study, we found that in the infection model of THP-1 derived human macrophages, which express multiple inflammasomes, <italic>E. tarda</italic> induced pyroptosis in a manner that depended on NLRC4, NLRP3, ASC, Casp1, and Casp4. This observation indicated that <italic>E. tarda</italic> infection activated both the canonical and the non-canonical inflammasome pathways, which might be due to the multiplicity of virulence factors expressed by <italic>E. tarda</italic>. In line with this result, cell death was nearly blocked when the bacteria were prevented from entering the host cell cytoplasm, suggesting that <italic>E. tarda</italic>-triggered cell death was an event that required direct interaction between the bacteria and the inflammasome molecules.</p><p>T3SS is one of the critical armaments of intracellular bacteria to combat the host’s defense system (<xref ref-type="bibr" rid="bib28">Portaliou et al., 2016</xref>; <xref ref-type="bibr" rid="bib7">Deng et al., 2017</xref>). T3SS delivers multiple bacterial effectors into host cells, which manipulate host immune responses to foster bacterial survival and expansion (<xref ref-type="bibr" rid="bib30">Raymond et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Ratner et al., 2017</xref>). This feature makes the T3SS apparatus readily exposed to the host cytosol, thus susceptible to detection by host receptors such as inflammasomes (<xref ref-type="bibr" rid="bib26">Miao et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Zhao et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Reyes Ruiz et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Kofoed and Vance, 2011</xref>; <xref ref-type="bibr" rid="bib29">Ratner et al., 2017</xref>). Studies have demonstrated that in mice, T3SS needle protein, T3SS rod protein, and flagellin are directly detected by NAIP1, NAIP2, and NAIP5/6, respectively (<xref ref-type="bibr" rid="bib45">Zhao et al., 2011</xref>; <xref ref-type="bibr" rid="bib17">Kofoed and Vance, 2011</xref>). In contrast, in humans, T3SS needle/rod proteins and flagellin are all detected by a single NAIP (<xref ref-type="bibr" rid="bib31">Reyes Ruiz et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Yang et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Kortmann et al., 2015</xref>). For <italic>E. tarda,</italic> two reports showed that flagellin was required to induce fish macrophage death (<xref ref-type="bibr" rid="bib40">Xie et al., 2014</xref>) but not required to induce murine macrophage death (<xref ref-type="bibr" rid="bib3">Chen et al., 2017</xref>). In our study, we found that flagellin was dispensable for <italic>E. tarda</italic>-induced pyroptosis of human macrophages. Consistently, the flagellin proteins were unable to activate human NAIP/NLRC4 inflammasomes. This observation differs from that of other pathogen flagellin proteins, which are recognized by NLRC4 inflammasomes (<xref ref-type="bibr" rid="bib45">Zhao et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Reyes Ruiz et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Kortmann et al., 2015</xref>). Like flagellin, the <italic>E. tarda</italic> rod protein EsaI also failed to activate the NLRC4 inflammasome. These results indicate that <italic>E. tarda</italic> flagellin and rod evade recognition by human NLRC4, probably as a strategy to facilitate bacterial infection. Unlike the needle, rod proteins, and flagellin, T3SS translocon proteins have seldom been reported to promote inflammasome activation and pyroptosis. Limited studies showed that the <italic>Yersinia</italic> translocon proteins YopD and YopB could translocate into host cells and indirectly activate inflammasome, resulting in cell death (<xref ref-type="bibr" rid="bib2">Casson et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Zwack et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Zwack et al., 2017</xref>); the translocon proteins of <italic>Pseudomonas aeruginosa</italic> PopB–PopD may be associated with inflammasome activation (<xref ref-type="bibr" rid="bib9">Dortet et al., 2018</xref>). Currently, it is unknown whether any inflammasome can directly recognize the translocon proteins. In the present study, mutational analyses showed that the translocon proteins were essential for <italic>E. tarda</italic> to induce pyroptosis and activate the non-canonical inflammasome Casp4. In particular, we found that the translocon protein EseB, when present intracellularly, sufficed to cause pyroptosis via NLRC4/NAIP. Moreover, the terminal residues proved to be vital for EseB activity, and the CT region alone could trigger pyroptosis in a manner similar to EseB. Consistently, although EseB differs dramatically from the NLRC4/NAIP-stimulating needle proteins in the NT region, it shares notable identities with the needle proteins in the CT region, suggesting a conserved mechanism of inflammasome activation via the CT region in these proteins.</p><p>Although T3SS is present in many bacterial pathogens, the particular mechanisms of T3SS translocon proteins, notably EseB, to induce host immune response are unclear. In this study, we identified EseB homologs in a large number of bacteria with T3SS and found that, like <italic>E. tarda</italic> EseB, all of these identified EseB homologs were able to activate NLRC4/NAIP, thus suggesting the wide existence of bacteria−host interaction mediated by EseB and the NLRC4/NAIP inflammasome. Sequence analysis revealed highly conserved T6R in all of the EseB homologs, which was crucial to NLRC4 inflammasome activation. Similar observation has been reported for the needle protein of T3SS. It has been shown that deletion of the last five amino acids from the needle protein prevented its self-association, so that the protein could exist only in the monomeric form, indicating the importance of these terminal amino acids in maintaining the stability of the high-order structure of the protein (<xref ref-type="bibr" rid="bib6">Deane et al., 2006</xref>; <xref ref-type="bibr" rid="bib43">Zhang et al., 2006</xref>; <xref ref-type="bibr" rid="bib37">Wang et al., 2007</xref>). In support of this, the cryo-electron microscopic structure of the needle−HsNAIP−HsNLRC4 complex showed that the last few amino acids of the needle were involved in interaction with human NAIP (<xref ref-type="bibr" rid="bib25">Matico et al., 2024</xref>). The importance of the last few residues is also suggested by the report that <italic>S. typhimurium</italic> SPI2 T3SS rod protein SsaI may evade NLRC4/NAIP inflammasome recognition by alteration in the last eight amino acids (<xref ref-type="bibr" rid="bib26">Miao et al., 2010</xref>). In our study, we found that the replacement of the terminal residues of EspA<sub>EHEC</sub> with that of EseB switched EspA<sub>EHEC</sub> to an NLRC4 activator. Similar observations were made with LcrV. These results suggest that the lack of EseB T6R-like terminal residues might be a strategy for EspA<sub>EHEC</sub> and LcrV to evade host immune detection. However, we also observed that IpaC and SipC, which possess EseB T6R-like terminal residues, failed to activate the NLRC4 inflammasome. Together these observations indicate that the terminal amino acids are a key, but not the sole, determinant in NLRC4 activation. Future studies are needed to find out the additional determinant(s) that work with the terminal residues to activate the NLRC4-mediated signaling.</p><p>In summary, our study demonstrated the importance and the mechanism of bacterial T3SS translocon in host interaction. We found that the translocon protein, EseB, triggered pyroptosis by directly activating the host NLRC4/NAIP inflammasome via the CT region, especially the T6R. Both the sequence and the inflammasome-stimulating function of the T6R were highly conserved in the EseB homologs of diverse bacteria. However, it must be said that for a translocator protein, the possession of a conserved T6R alone does not suffice to activate the NLRC4 inflammasome. These findings deepened the understanding of the function and mechanism of T3SS-mediated interaction between pathogens and hosts.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Edwardsiella tarda</italic> and others)</td><td align="left" valign="bottom">Translocon genes</td><td align="left" valign="bottom">GenBank, UniProtKB</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="supplementary-material" rid="supp1 supp2">Supplementary files 1 and 2</xref></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom"><italic>E. tarda</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Li et al., 2022</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom">Δ<italic>eseB</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">In-frame deletion of <italic>eseB</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom">Δ<italic>escA</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">In-frame deletion of <italic>escA</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom">Δ<italic>eseC</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">In-frame deletion of <italic>eseC</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom">Δ<italic>eseD</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">In-frame deletion of <italic>eseD</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom">Δ<italic>escB-D</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">In-frame deletion of <italic>eseB-eseD</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. tarda</italic>)</td><td align="left" valign="bottom">Δ<italic>fliC</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">In-frame deletion of <italic>fliC1/2</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">BL21(DE3)</td><td align="left" valign="bottom">TransGen Biotech</td><td align="left" valign="bottom">CD601</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HEK293T</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">Cat# CRL-3216, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:CVCL_0063">CVCL_0063</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP-1</td><td align="left" valign="bottom">Cell Resource Center, IBMS, CAMS/PUMC</td><td align="left" valign="bottom">1101HUM-PUMC000057, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:CVCL_0006">CVCL_0006</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-Null</td><td align="left" valign="bottom">InvivoGen</td><td align="left" valign="bottom">thp-null</td><td align="left" valign="bottom">Control cells</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-Casp1-KD</td><td align="left" valign="bottom">InvivoGen</td><td align="left" valign="bottom">thp-dcasp1</td><td align="left" valign="bottom"><italic>Casp1</italic> knockdown</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-NLRP3-KD</td><td align="left" valign="bottom">InvivoGen</td><td align="left" valign="bottom">thp-dnlp</td><td align="left" valign="bottom"><italic>Nlrp3</italic> knockdown</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-NLRC4-KO</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>Nlrc4</italic> knockout</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-Casp4-KO</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>Casp4</italic> knockout</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-Aim2-KO</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>Aim2</italic> knockout</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-ASC -KO</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Wang et al., 2024</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ASC</italic> knockout</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">THP1-GSDMD-KO</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Zhao et al., 2021</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>Gsdmd</italic> knockout</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">shRNA-NAIP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Lentiviral construct for <italic>NAIP</italic> knockdown</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>H. sapiens</italic>)</td><td align="left" valign="bottom">sgRNA-Aim2, Casp4, NLRC4</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Lentiviral construct for <italic>Aim2</italic>, <italic>Casp4</italic>, <italic>NLRC4 gene</italic> knockout</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Caspase-1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2225, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2243894">AB_2243894</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GSDMD (Rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 96458, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2894914">AB_2894914</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti- IL-1β (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 12703, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2737350">AB_2737350</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Caspase-4 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">42264T</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-6×His tag mAb (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab213204</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-flag-tag (Rabbit monoclonal)</td><td align="left" valign="bottom">ABclonal</td><td align="left" valign="bottom">Cat# AE063, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2771920">AB_2771920</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-HA-Tag (Mouse monoclonal)</td><td align="left" valign="bottom">ABclonal</td><td align="left" valign="bottom">Cat# AE008, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2770404">AB_2770404</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Myc-Tag (Mouse monoclonal)</td><td align="left" valign="bottom">ABclonal</td><td align="left" valign="bottom">Cat# AE010, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2770408">AB_2770408</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-β-actin (Mouse monoclonal)</td><td align="left" valign="bottom">ABclonal</td><td align="left" valign="bottom">Cat# AC004, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2737399">AB_2737399</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP goat anti-mouse IgG</td><td align="left" valign="bottom">ABclonal</td><td align="left" valign="bottom">Cat# AS003, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2769851">AB_2769851</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP goat anti-rabbit IgG</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab97051, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10679369">AB_10679369</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLKO.1 puro</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">8453, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_8453">Addgene_8453</ext-link></td><td align="left" valign="bottom">Negative control lentiviral construct</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDM4</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">The suicide plasmid</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET-28a</td><td align="left" valign="bottom">Novagen</td><td align="left" valign="bottom">69864</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCS2Flag</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">16331, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_16331">Addgene_16331</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">CytoTox 96 Non-Radioactive Cytotoxicity Assay kit</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">G1780</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Human IL-1β ELISA kit</td><td align="left" valign="bottom">NeoBioscience</td><td align="left" valign="bottom">EHC002B</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">cytochalasin B</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab143482</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">cytochalasin D</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">PHZ1063</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 10</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cells and cell culture</title><p>HEK293T (CRL-3216) and THP-1 (1101HUM-PUMC000057) cells were purchased from American type culture collection, ATCC and Cell Resource Center, IBMS, CAMS/PUMC, respectively. The cells were maintained at 37 °C in a 5% CO<sub>2</sub> humidified incubator. HEK293T cells were cultured in DMEM (C11995500, Gibco) supplemented with 10% (v/v) FBS (10099–141 C, Gibco), 1% penicillin, and streptomycin (SV30010, HyClone). THP-1 cells were cultured in complete RPMI 1640 medium composed of RPMI 1640 (C22400500, Gibco) medium supplemented with 10% (v/v) FBS and 1% penicillin and streptomycin. THP1-Null (control) (thp-null), THP1-Casp1-KD (<italic>Casp1</italic> knockdown) (thp-dcasp1), and THP1-NLRP3-KD (<italic>Nlrp3</italic> knockdown) (thp-dnlp) were obtained from InvivoGen and maintained as instructed by the manufacturer. All cell lines were authenticated by STR profiling and confirmed to be free of mycoplasma contamination.</p></sec><sec id="s4-2"><title>Gene knockout and knockdown</title><p>THP-1 cells with gene knockout were generated using the CRISPR-Cas9 system as described previously (<xref ref-type="bibr" rid="bib46">Zhao et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Wang et al., 2024</xref>). Briefly, the sgRNAs targeting Aim2 (5ʹ- <named-content content-type="sequence">TTCACGTTTGAGACCCAAGA</named-content>-3ʹ), Casp4 (5ʹ-<named-content content-type="sequence">TGGTGTTTTGGATAACTTGG</named-content>-3ʹ), and NLRC4 (5ʹ-<named-content content-type="sequence">CCACTACCACTGAGTGCCTG</named-content>-3’) were used for lentiviral constructs. The cells were treated with the lentiviral constructs and selected with puromycin. After selection, the gene knockout cells derived from single cells were further verified by PCR and sequence analysis. For <italic>NAIP</italic> gene knockdown via short hairpin RNA (shRNA), the oligo targeting <italic>NAIP</italic> (5’-<named-content content-type="sequence">CCGGGCCGTGGTGAACTTTGTGAATCTCGAGATTCACAAAGTTCACCACGGCTTTTTG</named-content>-3’ and 5’-<named-content content-type="sequence">AATTCAAAAAGCCGTGGTGAACTTTGTGAATCTCGAGATTCACAAAGTTCACCACGGC</named-content>-3’) was cloned into pLKO.1 puro (8453, Addgene), which was then used for lentiviral construct as above. The pLKO.1 scramble (1864, Addgene) was used for creating the negative control lentiviral construct. THP-1 cells were treated with the lentiviral constructs and selected as above. The knockdown efficiency was verified by RT-PCR with primers F (5’-<named-content content-type="sequence">GGCCAAACTGATCATCCAGC</named-content>-3’) and R (5’-<named-content content-type="sequence">TGGCATGTTGTCCAGTGCTT</named-content>-3’).</p></sec><sec id="s4-3"><title>Bacterial strains and culturing</title><p>The <italic>E. tarda</italic> mutants with markerless in-frame deletion of <italic>eseB</italic>, <italic>escA</italic>, <italic>eseC</italic>, <italic>eseD</italic>, <italic>eseB-eseD,</italic> and <italic>fliC1/2</italic> (Δ<italic>eseB</italic>, Δ<italic>escA</italic>, Δ<italic>eseC</italic>, Δ<italic>eseD</italic>, Δ<italic>eseB-D</italic> and Δ<italic>fliC</italic>, respectively) were constructed as reported previously (<xref ref-type="bibr" rid="bib23">Li et al., 2022</xref>; <xref ref-type="bibr" rid="bib24">Liu et al., 2022</xref>). Briefly, the fragments upstream and downstream of the target gene were amplified by overlapping PCR and inserted into the suicide plasmid pDM4. The recombinant plasmids were introduced into <italic>E. tarda</italic>, and mutant strains were generated by a two-step homologous recombination. The deletion of the target gene was confirmed by PCR and sequence analysis of the PCR products. The information on primers and the mutants is shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. <italic>E. tarda</italic> and its mutants were grown in Luria–Bertani (LB) medium supplemented with 20 μg/mL polymycin B (P8350, Solarbio) at 28 °C.</p></sec><sec id="s4-4"><title>Purification of recombinant proteins</title><p>The coding sequences of EscA, EseB, EseC, and EseD were amplified by PCR from the genome of <italic>E. tarda</italic>. All PCR products were cloned into the plasmid pET-28a (Novagen, 69864). <italic>E. coli</italic> BL21(DE3) (CD601, TransGen Biotech) was transformed with each of the recombinant plasmids, and the transformant was grown in LB medium at 37 °C until OD<sub>600</sub> 0.6. Isopropyl-β-D-thiogalactopyranoside (I8070, Solarbio) (0.2 mM) was added to the bacterial culture, and the culture was continued overnight at 16 °C. Bacteria were collected and lysed in Buffer A (20 mM Tris-HCl pH 8.0, 300 mM NaCl, and 10 mM imidazole). The recombinant proteins with His-tag were purified with Ni-NTA Agarose (30210, Qiagen). The proteins loaded onto the Ni-NTA column were washed with 60 column volumes of the Buffer B (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 40 mM imidazole, and 0.1% Triton X114), and then with 80 column volumes of Buffer C (20 mM Tris-HCl pH 8.0, 300 mM NaCl, and 40 mM imidazole). The proteins were finally eluted with Buffer D (20 mM Tris-HCl pH 8.0, 300 mM NaCl, and 250 mM imidazole) and dialyzed against Buffer E (20 mM Tris-HCl pH 8.0, and 150 mM NaCl). The purified proteins were subjected to SDS–PAGE. Protein concentrations were determined with the BCA Protein Assay Kit (P0010, Beyotime) according to the manufacturer’s instructions.</p></sec><sec id="s4-5"><title><italic>E. tarda</italic> infection in THP-1 cells</title><p>THP-1 cells were differentiated into macrophages with PMA overnight (<xref ref-type="bibr" rid="bib47">Zhao and Sun, 2022</xref>). <italic>E. tarda</italic> variants were cultured in LB medium with 20 μg/mL polymycin B at 28 °C until OD<sub>600</sub> 0.8. The bacteria were washed with PBS twice and then mixed with the differentiated THP-1 cells at MOI = 10. The mixture was centrifuged at 800 g for 8 min and incubated at 30 °C for 1 hr in a 5% CO<sub>2</sub> humidified incubator. To kill the extracellular bacteria, gentamycin (500 μg/mL) was added to the cells, followed by incubation for 0.5 hr. The culture medium was replaced with a fresh medium containing 40 μg/mL gentamycin. To prevent bacterial entry into cells, the cells were treated with 50 μM cytochalasin B (ab143482, Abcam) or 10 μM cytochalasin D (PHZ1063, Invitrogen) for 0.5 hr prior to infection.</p></sec><sec id="s4-6"><title>Protein electroporation</title><p>THP-1 cells were cultured in complete RPMI 1640 medium to a density of ~1×10<sup>6</sup> cells/mL. The cells were washed with precooled cytoporation medium T (47–0002, BTXpress) twice and resuspended in medium T to 5×10<sup>6</sup> cells/mL. Protein electroporation was performed using a Gemini X2 electroporator (45–2006, BTX) as follows. The protein (2 μg) was added to 1×10<sup>6</sup> cells in 200 μl medium T. Electroporation was then performed at the setting of 300 V, 10 ms, and 1 pulse. The cells were transferred into 1 mL pre-warmed OPTI-MEM medium (31985070, Gibco) and incubated for 1 hr. Then both cell lysates and supernatants were collected as described previously (<xref ref-type="bibr" rid="bib46">Zhao et al., 2021</xref>; <xref ref-type="bibr" rid="bib47">Zhao and Sun, 2022</xref>) for immunoblotting. Cell death was determined with CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (G1780, Promega).</p></sec><sec id="s4-7"><title>NLRC4 inflammasome reconstitution in HEK293T cells</title><p>The coding sequences of human NLRC4, NAIP, Casp1, and proIL-1β were cloned from PMA-differential THP-1 cells and inserted into pCS2Flag (16331, Addgene)-based expression vectors with different tags. The coding sequences of EseB homologs from various bacteria (GenBank accession numbers shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) were synthesized by Sangong Biotech (Shanghai, China). For NLRC4 inflammasome reconstitution, HEK293T cells were seeded into six-well plates overnight and then transfected with the indicated combination of plasmids (2 μg, 100 ng, 100 ng, 25 ng, and 100 ng for the plasmids expressing proIL-1β, NLRC4, NAIP, Casp1, and EseB, respectively) using Lipofectamine 3000 (L3000015, Invitrogen). At 24 hr post-transfection, the cells were lysed using RIPA buffer containing protease inhibitors. The cell lysates were analyzed by immunoblotting as described below.</p></sec><sec id="s4-8"><title>Immunoblotting and immunoprecipitation</title><p>Immunoblot was performed as reported previously (<xref ref-type="bibr" rid="bib47">Zhao and Sun, 2022</xref>) with the following antibodies: Caspase-1 antibody (2225 S, Cell Signaling Technology), GSDMD antibody (96458 S, Cell Signaling Technology), IL-1β rabbit mAb (12703 S, Cell Signaling Technology), Caspase-4 mAb (42,264T, Cell Signaling Technology), anti-6x His tag mAb (ab213204, Abcam), flag-tag rabbit mAb (AE063, ABclonal), mouse anti-HA-Tag mAb (AE008, ABclonal), mouse anti-Myc-tag mAb (AE010, ABclonal), β-actin mouse mAb (AC004, ABclonal), HRP goat anti-mouse IgG (H+L) (AS003, ABclonal), goat anti-rabbit IgG H&amp;L (HRP) (ab97051, Abcam). For immunoprecipitation, HEK293T cells transfected with the indicated plasmids were lysed in IP lysis buffer (50 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% triton X-100, and 1x protease inhibitor cocktail), followed by centrifugation at 14,000 g for 10 min to remove cell debris. The supernatants were mixed with equilibrated anti-FLAG M2 magnetic beads (M8823, sigma) according to the manufacturer’s instructions.</p></sec><sec id="s4-9"><title>Data analysis and statistics</title><p>Data were analyzed primarily using the Prism 10 software (<ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>). Statistical analysis was conducted using Student’s <italic>t</italic>-test for comparing two sets of data and one-way ANOVA for comparing three or more sets of data. Significance was defined as *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 and ****p&lt;0.0001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The primers used for the construction of <italic>Edwardsiella tarda</italic> translocon mutants.</title></caption><media xlink:href="elife-100820-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Translocator proteins used in this study.</title></caption><media xlink:href="elife-100820-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-100820-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript, supporting files and source data files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the Science &amp; Technology Innovation Project of Laoshan Laboratory (LSKJ202203000), the National Natural Science Foundation of China (31330081), and the National Key Research and Development Project of China (2018YFD0900500).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broz</surname><given-names>P</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inflammasomes: mechanism of assembly, regulation and signalling</article-title><source>Nature Reviews. Immunology</source><volume>16</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.58</pub-id><pub-id pub-id-type="pmid">27291964</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casson</surname><given-names>CN</given-names></name><name><surname>Copenhaver</surname><given-names>AM</given-names></name><name><surname>Zwack</surname><given-names>EE</given-names></name><name><surname>Nguyen</surname><given-names>HT</given-names></name><name><surname>Strowig</surname><given-names>T</given-names></name><name><surname>Javdan</surname><given-names>B</given-names></name><name><surname>Bradley</surname><given-names>WP</given-names></name><name><surname>Fung</surname><given-names>TC</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Brodsky</surname><given-names>IE</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Caspase-11 activation in response to bacterial secretion systems that access the host cytosol</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003400</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003400</pub-id><pub-id pub-id-type="pmid">23762026</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The bacterial t6ss effector EvpP prevents NLRP3 inflammasome activation by inhibiting the Ca<sup>2+</sup>-dependent MAPK-JNK pathway</article-title><source>Cell Host &amp; Microbe</source><volume>21</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.12.004</pub-id><pub-id pub-id-type="pmid">28081443</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dysregulated hemolysin liberates bacterial outer membrane vesicles for cytosolic lipopolysaccharide sensing</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007240</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007240</pub-id><pub-id pub-id-type="pmid">30138458</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christgen</surname><given-names>S</given-names></name><name><surname>Place</surname><given-names>DE</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Toward targeting inflammasomes: insights into their regulation and activation</article-title><source>Cell Research</source><volume>30</volume><fpage>315</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-0295-8</pub-id><pub-id pub-id-type="pmid">32152420</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deane</surname><given-names>JE</given-names></name><name><surname>Roversi</surname><given-names>P</given-names></name><name><surname>Cordes</surname><given-names>FS</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Kenjale</surname><given-names>R</given-names></name><name><surname>Daniell</surname><given-names>S</given-names></name><name><surname>Booy</surname><given-names>F</given-names></name><name><surname>Picking</surname><given-names>WD</given-names></name><name><surname>Picking</surname><given-names>WL</given-names></name><name><surname>Blocker</surname><given-names>AJ</given-names></name><name><surname>Lea</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Molecular model of a type III secretion system needle: Implications for host-cell sensing</article-title><source>PNAS</source><volume>103</volume><fpage>12529</fpage><lpage>12533</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602689103</pub-id><pub-id pub-id-type="pmid">16888041</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Marshall</surname><given-names>NC</given-names></name><name><surname>Rowland</surname><given-names>JL</given-names></name><name><surname>McCoy</surname><given-names>JM</given-names></name><name><surname>Worrall</surname><given-names>LJ</given-names></name><name><surname>Santos</surname><given-names>AS</given-names></name><name><surname>Strynadka</surname><given-names>NCJ</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Assembly, structure, function and regulation of type III secretion systems</article-title><source>Nature Reviews. Microbiology</source><volume>15</volume><fpage>323</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.20</pub-id><pub-id pub-id-type="pmid">28392566</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>S</given-names></name><name><surname>Chakravarty</surname><given-names>A</given-names></name><name><surname>Guha Biswas</surname><given-names>P</given-names></name><name><surname>De Guzman</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The type III secretion system needle, tip, and translocon</article-title><source>Protein Science</source><volume>28</volume><fpage>1582</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1002/pro.3682</pub-id><pub-id pub-id-type="pmid">31301256</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dortet</surname><given-names>L</given-names></name><name><surname>Lombardi</surname><given-names>C</given-names></name><name><surname>Cretin</surname><given-names>F</given-names></name><name><surname>Dessen</surname><given-names>A</given-names></name><name><surname>Filloux</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pore-forming activity of the <italic>Pseudomonas aeruginosa</italic> type III secretion system translocon alters the host epigenome</article-title><source>Nature Microbiology</source><volume>3</volume><fpage>378</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0109-7</pub-id><pub-id pub-id-type="pmid">29403015</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>MS</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name></person-group><article-title>Human and mouse NAIP/NLRC4 inflammasome responses to bacterial infection</article-title><source>Curr Opin Microbiol</source><year iso-8601-date="2023">2023</year><volume>73</volume><elocation-id>102298</elocation-id><pub-id pub-id-type="doi">10.1016/j.mib.2023.102298</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Orchestration of NLRP3 inflammasome activation by ion fluxes</article-title><source>Trends in Immunology</source><volume>39</volume><fpage>393</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.it.2018.01.009</pub-id><pub-id pub-id-type="pmid">29452983</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W</given-names></name><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Z-H</given-names></name><name><surname>Zhong</surname><given-names>C-Q</given-names></name><name><surname>Han</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion</article-title><source>Cell Research</source><volume>25</volume><fpage>1285</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1038/cr.2015.139</pub-id><pub-id pub-id-type="pmid">26611636</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>Y</given-names></name><name><surname>Asahata-Tago</surname><given-names>S</given-names></name><name><surname>Ainoda</surname><given-names>Y</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Edwardsiella tarda bacteremia: a rare but fatal water- and foodborne infection: Review of the literature and clinical cases from A single centre</article-title><source>The Canadian Journal of Infectious Diseases &amp; Medical Microbiology = Journal Canadien Des Maladies Infectieuses et de La Microbiologie Medicale</source><volume>26</volume><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1155/2015/702615</pub-id><pub-id pub-id-type="pmid">26744588</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>MM</given-names></name><name><surname>O’Neill</surname><given-names>LAJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metabolic regulation of NLRP3</article-title><source>Immunological Reviews</source><volume>281</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1111/imr.12608</pub-id><pub-id pub-id-type="pmid">29247992</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Intracellular innate immune receptors: Life inside the cell</article-title><source>Immunological Reviews</source><volume>297</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/imr.12912</pub-id><pub-id pub-id-type="pmid">32856334</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayagaki</surname><given-names>N</given-names></name><name><surname>Stowe</surname><given-names>IB</given-names></name><name><surname>Lee</surname><given-names>BL</given-names></name><name><surname>O’Rourke</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>K</given-names></name><name><surname>Warming</surname><given-names>S</given-names></name><name><surname>Cuellar</surname><given-names>T</given-names></name><name><surname>Haley</surname><given-names>B</given-names></name><name><surname>Roose-Girma</surname><given-names>M</given-names></name><name><surname>Phung</surname><given-names>QT</given-names></name><name><surname>Liu</surname><given-names>PS</given-names></name><name><surname>Lill</surname><given-names>JR</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Kummerfeld</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Snipas</surname><given-names>SJ</given-names></name><name><surname>Salvesen</surname><given-names>GS</given-names></name><name><surname>Morris</surname><given-names>LX</given-names></name><name><surname>Fitzgerald</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bertram</surname><given-names>EM</given-names></name><name><surname>Goodnow</surname><given-names>CC</given-names></name><name><surname>Dixit</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling</article-title><source>Nature</source><volume>526</volume><fpage>666</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1038/nature15541</pub-id><pub-id pub-id-type="pmid">26375259</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kofoed</surname><given-names>EM</given-names></name><name><surname>Vance</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity</article-title><source>Nature</source><volume>477</volume><fpage>592</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1038/nature10394</pub-id><pub-id pub-id-type="pmid">21874021</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kortmann</surname><given-names>J</given-names></name><name><surname>Brubaker</surname><given-names>SW</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cutting Edge: inflammasome activation in primary human macrophages is dependent on flagellin</article-title><source>Journal of Immunology</source><volume>195</volume><fpage>815</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1403100</pub-id><pub-id pub-id-type="pmid">26109648</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>KY</given-names></name><name><surname>Siame</surname><given-names>BA</given-names></name><name><surname>Tenkink</surname><given-names>BJ</given-names></name><name><surname>Noort</surname><given-names>RJ</given-names></name><name><surname>Mok</surname><given-names>YK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Edwardsiella tarda - virulence mechanisms of an emerging gastroenteritis pathogen</article-title><source>Microbes and Infection</source><volume>14</volume><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2011.08.005</pub-id><pub-id pub-id-type="pmid">21924375</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>KY</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Siame</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Edwardsiella piscicida</italic>: A versatile emerging pathogen of fish</article-title><source>Virulence</source><volume>10</volume><fpage>555</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1080/21505594.2019.1621648</pub-id><pub-id pub-id-type="pmid">31122125</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>KY</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Zhuang</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name><name><surname>Achmon</surname><given-names>Y</given-names></name><name><surname>Siame</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Versatile lifestyles of <italic>Edwardsiella</italic>: Free-living, pathogen, and core bacterium of the aquatic resistome</article-title><source>Virulence</source><volume>13</volume><fpage>5</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1080/21505594.2021.2006890</pub-id><pub-id pub-id-type="pmid">34969351</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HL</given-names></name><name><surname>Sun</surname><given-names>BG</given-names></name><name><surname>Ning</surname><given-names>XH</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A comparative analysis of edwardsiella tarda-induced transcriptome profiles in RAW264.7 cells reveals new insights into the strategy of bacterial immune evasion</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>5724</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20225724</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Edwardsiella tarda TraT is an anti-complement factor and a cellular infection promoter</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>637</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-03587-3</pub-id><pub-id pub-id-type="pmid">35768577</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The involvement of thiamine uptake in the virulence of <italic>Edwardsiella piscicida</italic></article-title><source>Pathogens</source><volume>11</volume><elocation-id>464</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens11040464</pub-id><pub-id pub-id-type="pmid">35456139</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matico</surname><given-names>RE</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Miller</surname><given-names>R</given-names></name><name><surname>Somani</surname><given-names>S</given-names></name><name><surname>Ricketts</surname><given-names>MD</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Steele</surname><given-names>RA</given-names></name><name><surname>Medley</surname><given-names>Q</given-names></name><name><surname>Berger</surname><given-names>S</given-names></name><name><surname>Faustin</surname><given-names>B</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Structural basis of the human NAIP/NLRC4 inflammasome assembly and pathogen sensing</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>31</volume><fpage>82</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/s41594-023-01143-z</pub-id><pub-id pub-id-type="pmid">38177670</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>EA</given-names></name><name><surname>Mao</surname><given-names>DP</given-names></name><name><surname>Yudkovsky</surname><given-names>N</given-names></name><name><surname>Bonneau</surname><given-names>R</given-names></name><name><surname>Lorang</surname><given-names>CG</given-names></name><name><surname>Warren</surname><given-names>SE</given-names></name><name><surname>Leaf</surname><given-names>IA</given-names></name><name><surname>Aderem</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome</article-title><source>PNAS</source><volume>107</volume><fpage>3076</fpage><lpage>3080</lpage><pub-id pub-id-type="doi">10.1073/pnas.0913087107</pub-id><pub-id pub-id-type="pmid">20133635</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>J</given-names></name><name><surname>Kiriyama</surname><given-names>M</given-names></name><name><surname>Suzaki</surname><given-names>E</given-names></name><name><surname>Kataoka</surname><given-names>K</given-names></name><name><surname>Nishibuchi</surname><given-names>M</given-names></name><name><surname>Nakai</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Characterization of proteins secreted from a type III secretion system of Edwardsiella tarda and their roles in macrophage infection</article-title><source>Diseases of Aquatic Organisms</source><volume>84</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.3354/dao02033</pub-id><pub-id pub-id-type="pmid">19476281</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portaliou</surname><given-names>AG</given-names></name><name><surname>Tsolis</surname><given-names>KC</given-names></name><name><surname>Loos</surname><given-names>MS</given-names></name><name><surname>Zorzini</surname><given-names>V</given-names></name><name><surname>Economou</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Type III Secretion: building and operating a remarkable nanomachine</article-title><source>Trends in Biochemical Sciences</source><volume>41</volume><fpage>175</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2015.09.005</pub-id><pub-id pub-id-type="pmid">26520801</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratner</surname><given-names>D</given-names></name><name><surname>Orning</surname><given-names>MPA</given-names></name><name><surname>Lien</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Bacterial secretion systems and regulation of inflammasome activation</article-title><source>Journal of Leukocyte Biology</source><volume>101</volume><fpage>165</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1189/jlb.4MR0716-330R</pub-id><pub-id pub-id-type="pmid">27810946</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname><given-names>B</given-names></name><name><surname>Young</surname><given-names>JC</given-names></name><name><surname>Pallett</surname><given-names>M</given-names></name><name><surname>Endres</surname><given-names>RG</given-names></name><name><surname>Clements</surname><given-names>A</given-names></name><name><surname>Frankel</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors</article-title><source>Trends in Microbiology</source><volume>21</volume><fpage>430</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2013.06.008</pub-id><pub-id pub-id-type="pmid">23870533</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes Ruiz</surname><given-names>VM</given-names></name><name><surname>Ramirez</surname><given-names>J</given-names></name><name><surname>Naseer</surname><given-names>N</given-names></name><name><surname>Palacio</surname><given-names>NM</given-names></name><name><surname>Siddarthan</surname><given-names>IJ</given-names></name><name><surname>Yan</surname><given-names>BM</given-names></name><name><surname>Boyer</surname><given-names>MA</given-names></name><name><surname>Pensinger</surname><given-names>DA</given-names></name><name><surname>Sauer</surname><given-names>J-D</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Broad detection of bacterial type III secretion system and flagellin proteins by the human NAIP/NLRC4 inflammasome</article-title><source>PNAS</source><volume>114</volume><fpage>13242</fpage><lpage>13247</lpage><pub-id pub-id-type="doi">10.1073/pnas.1710433114</pub-id><pub-id pub-id-type="pmid">29180436</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seoane</surname><given-names>PI</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Hoyle</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Lopez-Castejon</surname><given-names>G</given-names></name><name><surname>Lowe</surname><given-names>M</given-names></name><name><surname>Brough</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The NLRP3-inflammasome as a sensor of organelle dysfunction</article-title><source>The Journal of Cell Biology</source><volume>219</volume><elocation-id>e202006194</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.202006194</pub-id><pub-id pub-id-type="pmid">33044555</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death</article-title><source>Nature</source><volume>526</volume><fpage>660</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1038/nature15514</pub-id><pub-id pub-id-type="pmid">26375003</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storek</surname><given-names>KM</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Bacterial recognition pathways that lead to inflammasome activation</article-title><source>Immunological Reviews</source><volume>265</volume><fpage>112</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1111/imr.12289</pub-id><pub-id pub-id-type="pmid">25879288</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sui</surname><given-names>ZH</given-names></name><name><surname>Xu</surname><given-names>HJ</given-names></name><name><surname>Wang</surname><given-names>HD</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Chi</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intracellular Trafficking Pathways of <italic>Edwardsiella tarda</italic>: from clathrin- and caveolin-mediated endocytosis to endosome and lysosome</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>7</volume><elocation-id>400</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00400</pub-id><pub-id pub-id-type="pmid">28932708</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>YP</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Tung</surname><given-names>SL</given-names></name><name><surname>Rosenshine</surname><given-names>I</given-names></name><name><surname>Leung</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Role of type III secretion in Edwardsiella tarda virulence</article-title><source>Microbiology</source><volume>151</volume><fpage>2301</fpage><lpage>2313</lpage><pub-id pub-id-type="doi">10.1099/mic.0.28005-0</pub-id><pub-id pub-id-type="pmid">16000720</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ouellette</surname><given-names>AN</given-names></name><name><surname>Egan</surname><given-names>CW</given-names></name><name><surname>Rathinavelan</surname><given-names>T</given-names></name><name><surname>Im</surname><given-names>W</given-names></name><name><surname>De Guzman</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Differences in the electrostatic surfaces of the type III secretion needle proteins PrgI, BsaL, and MxiH</article-title><source>Journal of Molecular Biology</source><volume>371</volume><fpage>1304</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.06.034</pub-id><pub-id pub-id-type="pmid">17617421</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Mo</surname><given-names>ZL</given-names></name><name><surname>Mao</surname><given-names>YX</given-names></name><name><surname>Zou</surname><given-names>YX</given-names></name><name><surname>Xiao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>JY</given-names></name><name><surname>Ye</surname><given-names>XH</given-names></name><name><surname>Leung</surname><given-names>KY</given-names></name><name><surname>Zhang</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Investigation of EscA as a chaperone for the Edwardsiella tarda type III secretion system putative translocon component EseC</article-title><source>Microbiology</source><volume>155</volume><fpage>1260</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1099/mic.0.021865-0</pub-id><pub-id pub-id-type="pmid">19332827</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Haemolysins are essential to the pathogenicity of deep-sea Vibrio fluvialis</article-title><source>iScience</source><volume>27</volume><elocation-id>109558</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2024.109558</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>H-X</given-names></name><name><surname>Lu</surname><given-names>J-F</given-names></name><name><surname>Rolhion</surname><given-names>N</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name><name><surname>Nie</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>X-J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Edwardsiella tarda-Induced cytotoxicity depends on its type III secretion system and flagellin</article-title><source>Infection and Immunity</source><volume>82</volume><fpage>3436</fpage><lpage>3445</lpage><pub-id pub-id-type="doi">10.1128/IAI.01065-13</pub-id><pub-id pub-id-type="pmid">24891103</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Edwardsiella piscicida virulence effector trxlp promotes the NLRC4 inflammasome activation during infection</article-title><source>Microbial Pathogenesis</source><volume>123</volume><fpage>496</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.08.016</pub-id><pub-id pub-id-type="pmid">30118802</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation</article-title><source>PNAS</source><volume>110</volume><fpage>14408</fpage><lpage>14413</lpage><pub-id pub-id-type="doi">10.1073/pnas.1306376110</pub-id><pub-id pub-id-type="pmid">23940371</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Picking</surname><given-names>WL</given-names></name><name><surname>Picking</surname><given-names>WD</given-names></name><name><surname>De Guzman</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Solution structure of monomeric BsaL, the type III secretion needle protein of Burkholderia pseudomallei</article-title><source>Journal of Molecular Biology</source><volume>359</volume><fpage>322</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2006.03.028</pub-id><pub-id pub-id-type="pmid">16631790</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Ni</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Dai</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intramacrophage infection reinforces the virulence of edwardsiella tarda</article-title><source>Journal of Bacteriology</source><volume>198</volume><fpage>1534</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1128/JB.00978-15</pub-id><pub-id pub-id-type="pmid">26953340</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>Y-N</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus</article-title><source>Nature</source><volume>477</volume><fpage>596</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/nature10510</pub-id><pub-id pub-id-type="pmid">21918512</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Guan</surname><given-names>XL</given-names></name><name><surname>Sun</surname><given-names>BG</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A virulent    <italic>Bacillus cereus</italic>    strain from deep-sea cold seep induces pyroptosis in A manner that involves NLRP3 inflammasome, JNK pathway, and lysosomal rupture</article-title><source>Virulence</source><volume>12</volume><fpage>1362</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1080/21505594.2021.1926649</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Bacillus cereus cytotoxin K triggers gasdermin D-dependent pyroptosis</article-title><source>Cell Death Discovery</source><volume>8</volume><elocation-id>305</elocation-id><pub-id pub-id-type="doi">10.1038/s41420-022-01091-5</pub-id><pub-id pub-id-type="pmid">35788609</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwack</surname><given-names>EE</given-names></name><name><surname>Snyder</surname><given-names>AG</given-names></name><name><surname>Wynosky-Dolfi</surname><given-names>MA</given-names></name><name><surname>Ruthel</surname><given-names>G</given-names></name><name><surname>Philip</surname><given-names>NH</given-names></name><name><surname>Marketon</surname><given-names>MM</given-names></name><name><surname>Francis</surname><given-names>MS</given-names></name><name><surname>Bliska</surname><given-names>JB</given-names></name><name><surname>Brodsky</surname><given-names>IE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD</article-title><source>mBio</source><volume>6</volume><elocation-id>e02095-14</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02095-14</pub-id><pub-id pub-id-type="pmid">25691590</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwack</surname><given-names>EE</given-names></name><name><surname>Feeley</surname><given-names>EM</given-names></name><name><surname>Burton</surname><given-names>AR</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name><name><surname>Bliska</surname><given-names>JB</given-names></name><name><surname>Coers</surname><given-names>J</given-names></name><name><surname>Brodsky</surname><given-names>IE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Guanylate binding proteins regulate inflammasome activation in response to hyperinjected yersinia translocon components</article-title><source>Infection and Immunity</source><volume>85</volume><elocation-id>e00778-16</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00778-16</pub-id><pub-id pub-id-type="pmid">28784930</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100820.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sohn</surname><given-names>Jungsan</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study shows that Type 3 secretion translocons in Edwardsiella tarda and other bacteria activate the NAIP-NLRC4 inflammasome. The data from cellular and biochemical experiments showing that EseB is required for activation of the NLRC4 inflammasome are <bold>convincing</bold>. This paper is broadly relevant to those investigating host-pathogen interactions in diverse organisms.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100820.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this study, Zhao and colleagues investigate inflammasome activation by E. tarda infections. They show that E. tarda induces the activation of the NLRC4 inflammasome as well as the non-canonical pathway in human THP1 macrophages. Further dissecting NLRC4 activation, the find that T3SS translocon components eseB, eseC and eseD are necessary for NLRC4 activation, and that delivery of purified eseB is sufficient to trigger NAIP-dependnet NLRC4 activation. Sequence analysis reveals that eseB shares homology within the C-terminus with T3SS needle and rod proteins, leading the authors to test if this region is necessary for inflammasome activation. They show that the eseB CT is required and that it mediates interaction with NAIP. Finally, they that homologs of eseB in other bacteria also share the same sequence and that they can activate NLRC4 in a HEK293T cell overexpression system.</p><p>Strengths:</p><p>This is a very nice study that convincingly shows that eseB and its homologs can be recognized by the human NAIP/NLRC4 inflammasome. The experiments are well-designed, controlled and described, and the papers is convincing as a whole.</p><p>Weaknesses:</p><p>The authors need to discuss their study in the context of previous papers that have shown an important role for E. tarda flagellin in inflammasome activation and test whether flagellin and/or E. tarda T3SSs needle or rod can activate NLRC4.</p><p>The authors show that eseB and its homologs can activate NLRC4, but there are also other translocon proteins that are very different such as YopB or PopB. and share little homology with eseB. It would be nice to include a section comparing the different type 3 secretion systems. are there 2 different families of T3SSs, those that feature translocon components that are recognized by NAIP-NLRC4 and those that cannot be recognized?</p><p>Comments on revisions:</p><p>The authors have addressed my concern with additional experiments, which strengthen the authors' conclusions.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100820.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This work by Zhao et al. demonstrates the role of the Edwardsiella tarda type 3 secretion system translocon in activating human macrophage inflammation and pyroptosis. The authors show the requirement of both the bacterial translocon proteins and particular host inflammasome components for E. tarda-induced pyroptosis. In addition, the authors show that the C-terminal region of the translocon protein, EseB, is both necessary and sufficient to induce pyroptosis when present in the cytoplasm. The most terminal region of EseB was determined to be highly conserved among other T3SS-encoding pathogenic bacteria and a subset of these exhibited functionally similar effects on inflammasome activation. Overall, the data support the conclusions and interpretations and provide valuable insights into interactions between bacterial T3SS components and the host immune system., thereby expanding our understanding of E. tarda pathogenesis.</p><p>Strengths:</p><p>The authors use established and reliable molecular biology and bacterial genetics strategies to characterize the roles of the bacterial T3SS translocon and host inflammasome pathways to E. tarda-induced pyroptosis in human macrophages. These observations are naturally expanded upon by demonstrating the specific regions of EseB that are required for inflammasome activation and the conservation of this sequence and function among other pathogenic bacteria.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100820.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Yan</given-names></name><role specific-use="author">Author</role><aff><institution>Tsinghua University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Hanshuo</given-names></name><role specific-use="author">Author</role><aff><institution>Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jinqian</given-names></name><role specific-use="author">Author</role><aff><institution>Tsinghua University</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Hang</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Oceanology, Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Li</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Oceanology, Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>In this study, Zhao and colleagues investigate inflammasome activation by E. tarda infections. They show that E. tarda induces the activation of the NLRC4 inflammasome as well as the non-canonical pathway in human THP1 macrophages. Further dissecting NLRC4 activation, they find that T3SS translocon components eseB, eseC and eseD are necessary for NLRC4 activation and that delivery of purified eseB is sufficient to trigger NAIP-dependent NLRC4 activation. Sequence analysis reveals that eseB shares homology within the C-terminus with T3SS needle and rod proteins, leading the authors to test if this region is necessary for inflammasome activation. They show that the eseB CT is required and that it mediates interaction with NAIP. Finally, they that homologs of eseB in other bacteria also share the same sequence and that they can activate NLRC4 in a HEK293T cell overexpression system.</p><p>Strengths:</p><p>This is a very nice study that convincingly shows that eseB and its homologs can be recognized by the human NAIP/NLRC4 inflammasome. The experiments are well designed, controlled and described, and the papers is convincing as a whole.</p><p>Weaknesses:</p><p>The authors need to discuss their study in the context of previous papers that have shown an important role for E. tarda flagellin in inflammasome activation and test whether flagellin and/or E. tarda T3SSs needle or rod can activate NLRC4.</p><p>The authors show that eseB and its homologs can activate NLRC4, but there are also other translocon proteins that are very different such as YopB or PopB. and share little homology with eseB. It would be nice to include a section comparing the different type 3 secretion systems. are there 2 different families of T3SSs, those that feature translocon components that are recognized by NAIP-NLRC4 and those that cannot be recognized?</p><p>(1) The authors need to discuss their study in the context of previous papers that have shown an important role for E. tarda flagellin in inflammasome activation and test whether flagellin and/or E. tarda T3SSs needle or rod can activate NLRC4.</p></disp-quote><p>According to the reviewer’s suggestion, we added the relevant discussion (lines 326-334) and carried out additional experiments to examine whether <italic>E. tarda</italic> flagellin, needle, and rod could activate NLRC4. The relevant results are shown in Figure S3, Figure S5, and lines 226-230 and 269-274.</p><disp-quote content-type="editor-comment"><p>(2) The authors show that eseB and its homologs can activate NLRC4, but there are also other translocon proteins that are very different such as YopB or PopB. and share little homology with eseB. It would be nice to include a section comparing the different type 3 secretion systems. are there 2 different families of T3SSs, those that feature translocon components that are recognized by NAIP-NLRC4 and those that cannot be recognized?</p></disp-quote><p>According to the reviewer’s suggestion, additional experiments were performed to examine the NLRC4-activating potentials of 14 translocator proteins that share low sequence identities with EseB. The relevant results and discussion are shown in Figure S8 and lines 289-301; 364-372, and 377-379.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>This work by Zhao et al. demonstrates the role of the Edwardsiella tarda type 3 secretion system translocon in activating human macrophage inflammation and pyroptosis. The authors show the requirement of both the bacterial translocon proteins and particular host inflammasome components for E. tarda-induced pyroptosis. In addition, the authors show that the C-terminal region of the translocon protein, EseB, is both necessary and sufficient to induce pyroptosis when present in the cytoplasm. The most terminal region of EseB was determined to be highly conserved among other T3SS-encoding pathogenic bacteria and a subset of these exhibited functionally similar effects on inflammasome activation. Overall, the data support the conclusions and interpretations and provide interesting insights into interactions between bacterial T3SS components and the host immune system.</p><p>Strengths:</p><p>The authors use established and reliable molecular biology and bacterial genetics strategies to characterize the roles of the bacterial T3SS translocon and host inflammasome pathways to E. tarda-induced pyroptosis in human macrophages. These observations are naturally expanded upon by demonstrating the specific regions of EseB that are required for inflammasome activation and the conservation of this sequence among other pathogenic bacteria.</p><p>Weaknesses:</p><p>The functional assessment of EseB homologues is limited to inflammasome activation at the protein level but does not include the effects on cell viability as shown for E. tarda EseB. Confirmation that EseB homologues have similar effects on cell death would strengthen this portion of the manuscript.</p></disp-quote><p>According to the reviewer’s suggestion, the effects of representative EseB homologs on cell death were examined in the revised manuscripts (Figure 5D, Figure S7 and line 289).</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>I only have a few suggestions on how to improve the study:</p><p>Activation of caspase-4 requires entry into the host cytosol. Can this be observed with E. tarda and is it T3SS dependent? The fact that deleting the translocon components abrogates all GSDMD activation (see Fig. 2D) suggests that also Casp4 activation requires an active T3SS. It would be useful for the reader to include some more information on the cellular biology of E. tarda.</p></disp-quote><p>In our study, we found that <italic>E. tarda</italic> could enter THP-1 cells (Figure S1), and host cell entry was not affected by deletion of <italic>eseB-D</italic> (Δ<italic>eseB-D</italic>) in the T3SS system (Figure 2B, C). Additional experiments showed that Δ<italic>eseB-D</italic> abolished the ability of <italic>E. tarda</italic> to activate Casp4 (Figure S2), implying that Casp4 activation required an active T3SS. Relevant changes in the revised manuscript: lines 223 and 224, 341-342.</p><disp-quote content-type="editor-comment"><p>The data presented by the authors suggest that escB is sensed by NLRC4 when overexpressed, they do however not prove that during an infection escB is the main factor that drives NLRC4 activation, since deficiency in escB also abrogated translocation of other potential activators of NLRC4, e.g. flagellin and T3SS needle and rod subunits. I would thus find it essential to properly test if E. tarda flagellin can activate NLRC4 by comparing a WT and flagellin deficient strain, and/or by transfecting or expressing E.t. flagellin in these cells, as well as testing whether E.t. rod and needle subunits act as NLRC4 activators. This is important as previous studies suggested that flagellin is the main activator of cytotoxicity during E. tarda infection.</p></disp-quote><p>Previous studies have shown that flagellin is required for <italic>E. tarda</italic>-induced macrophage death in fish [1] but not in mice [2]. In the revised manuscript, we performed additional experiments to examine whether <italic>E. tarda</italic> flagellin, needle, and rod could activate NLRC4. The relevant results are shown in Figure S3, Figure S5, and lines 226-230 and 269-274, and 326-334.</p><p>References</p><p>(1) Xie HX, Lu JF, Rolhion N, Holden DW, Nie P, Zhou Y, et al. <italic>Edwardsiella tarda</italic>-induced cytotoxicity depends on its type III secretion system and flagellin. Infect Immun. 2014;82(8):3436-45. doi: 10.1128/IAI.01065-13.</p><p>(2) Chen H, Yang D, Han F, Tan J, Zhang L, Xiao J, et al. The bacterial T6SS effector EvpP prevents NLRP3 inflammasome activation by inhibiting the Ca<sup>2+</sup>-dependent MAPK-JNK pathway. Cell Host Microbe. 2017;21(1):47-58. doi: 10.1016/j.chom.2016.12.004.</p><disp-quote content-type="editor-comment"><p>Figure 5/S4, please list the names of the eseB homologs. It is cumbersome to have to access GenBank with the accession number to be able to understand what proteins the authors define as homologs of eseB.</p></disp-quote><p>The names were added to the revised Table S2, Figure 5 and Figure S6 (the original Figure S4).</p><disp-quote content-type="editor-comment"><p>The authors mention that other translocon proteins, such as YopB/D and PopB/D, were suggested to cause inflammasome activation. How do these compare to eseB and its homologs? Do they share the CT motif?</p></disp-quote><p>Additional experiments were performed to compare the inflammasome activation abilities of EseB and other translocator proteins including YopD and PopD. The relevant results and discussion are shown in Figure S8 and lines 289-301, 364-372, and 377-379.</p><disp-quote content-type="editor-comment"><p>It would be nice to show that there are potentially two groups of translocon proteins, one group sharing homology to needle subunits within the CT region and another that is different. A quick look at the sequence of these proteins suggests that they are quite different and much larger than eseB.</p></disp-quote><p>In our study, additional experiments with more translocator proteins indicated that the possession of EseB T6R-like terminal residues does not necessarily guarantee the protein to activate the NLRC4 inflammasome. Relevant results and discussion are shown in lines 289-301, 364-372, and 377-379.</p></body></sub-article></article>